Preprint · CC-BY
via OpenAlex
Genotoxic colibactin mutational signature in colorectal cancer is associated with clinicopathological features, specific genomic alterations and better survival
Peter Georgeson, Robert S. Steinfelder, Tabitha A. Harrison, Bernard J. Pope, Syed Hassan Ejaz Zaidi, Conghui Qu, Yi Lin, Jihoon E. Joo, Khalid Mahmood, Mark Clendenning, Romy Walker, Elom K. Aglago, Sonja I. Berndt, Hermann Brenner, Peter T. Campbell
medRxiv · 2023 · ▲ 24 citations
Abstract
ABSTRACT Background and Aims The microbiome has long been suspected of a role in colorectal cancer (CRC) tumorigenesis. The mutational signature SBS88 mechanistically links CRC development with the strain of Escherichia coli harboring the pks island that produces the genotoxin colibactin, but the genomic, pathological and survival characteristics associated with SBS88-positive tumors are unknown. Methods SBS88-positive CRCs were identified from targeted sequencing data from 5,292 CRCs from 17 studies and tested for their association with clinico-pathological features, oncogenic pathways, genomic characteristics and survival. Results In total, 7.5% (398/5,292) of the CRCs were SBS88-positive, of which 98.7% (392/398) were microsatellite stable/microsatellite instability low (MSS/MSI-L), compared with 80% (3916/4894) of SBS88 negative tumors (p=1.5×10 -28 ). Analysis of MSS/MSI-L CRCs demonstrated that SBS88 positive CRCs were associated with the distal colon (OR=1.84, 95% CI=1.40-2.42, p=1×10 -5 ) and rectum (OR=1.90, 95% CI=1.44-2.51, p=6×10 -6 ) tumor sites compared with the proximal colon. The top seven recurrent somatic mutations associated with SBS88-positive CRCs demonstrated mutational contexts associated with colibactin-induced DNA damage, the strongest of which was the APC :c.835-8A>G mutation (OR=65.5, 95%CI=39.0-110.0, p=3×10 -80 ). Large copy number alterations (CNAs) including CNA loss on 14q and gains on 13q, 16q and 20p were significantly enriched in SBS88- positive CRCs. SBS88-positive CRCs were associated with better CRC-specific survival (p=0.007; hazard ratio of 0.69, 95% CI=0.52-0.90) when stratified by age, sex, study, and by stage. Conclusion SBS88-positivity, a biomarker of colibactin-induced DNA damage, can identify a novel subtype of CRC characterized by recurrent somatic mutations, copy number alterations and better survival. These findings provide new insights for treatment and prevention strategies for this subtype of CRC.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1101/2023.03.10.23287127
- Canonical
- link ↗
- Fetched
- 2026-06-07 MST
Cite this
APA
Georgeson, P., Steinfelder, R.S., Harrison, T.A., Pope, B.J., Zaidi, S.H.E., Qu, C., Lin, Y., Joo, J.E., Mahmood, K., Clendenning, M., Walker, R., Aglago, E.K., Berndt, S.I., Brenner, H., Campbell, P.T., Cao, Y., Chan, A.T., Chang‐Claude, J., Dimou, N., & Doheny, K.F. (2023). Genotoxic colibactin mutational signature in colorectal cancer is associated with clinicopathological features, specific genomic alterations and better survival. <em>medRxiv</em>. https://doi.org/10.1101/2023.03.10.23287127
Vancouver
Georgeson P, Steinfelder RS, Harrison TA, Pope BJ, Zaidi SHE, Qu C, et al. Genotoxic colibactin mutational signature in colorectal cancer is associated with clinicopathological features, specific genomic alterations and better survival. medRxiv. 2023. doi:10.1101/2023.03.10.23287127.
BibTeX
@unpublished{peter2023Genoto,
title = {Genotoxic colibactin mutational signature in colorectal cancer is associated with clinicopathological features, specific genomic alterations and better survival},
author = {Peter Georgeson and Robert S. Steinfelder and Tabitha A. Harrison and Bernard J. Pope and Syed Hassan Ejaz Zaidi and Conghui Qu and Yi Lin and Jihoon E. Joo and Khalid Mahmood and Mark Clendenning and Romy Walker and Elom K. Aglago and Sonja I. Berndt and Hermann Brenner and Peter T. Campbell and Yin Cao and Andrew T. Chan and Jenny Chang‐Claude and Niki Dimou and Kimberly F. Doheny and David A. Drew and Jane C. Figueiredo and Amy J. French and Steven Gallinger and Marios Giannakis},
journal = {medRxiv},
year = {2023},
doi = {10.1101/2023.03.10.23287127},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Cell Research 2005
Citation only
Epigenetic alterations in gastric carcinogenesis
bioRxiv (Cold Spring Harbor Laboratory) 2025
Preprint · CC-BY
Epigenetic age prediction using N6-methyladenine in the bumblebee Bombus terrestris
Human Molecular Genetics 2001
Citation only
Molecular genetics of age-related macular degeneration
Molecular Biology and Evolution 2021
Open access · CC-BY
Conservation of Aging and Cancer Epigenetic Signatures across Human and Mouse
Clinical Epigenetics 2020
Open access · CC-BY
Reduced DNA methylation of the oxytocin receptor gene is associated with obsessive-compulsive disorder
Cancer 2005
Open access · OA